5 things to know about Gossamer Bio, a biotech with a surprisingly diverse pipeline
January 31, 2019 at 11:22 AM EST
Gossamer Bio, Inc., a company with six drugs in its pipeline, is planing to go public and has applied to list on the Nasdaq exchange.